You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 284 No. 8, August 23, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Utility of Endoscopic Screening for Upper Gastrointestinal Adenocarcinoma

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The incidence of esophageal and gastric cardia adenocarcinoma is increasing in Western Europe and the United States.1 Survival rates2 are substantially improved by early tumor detection.3 Therefore, it seems important to identify high-risk persons in whom endoscopic surveillance might be warranted. Recently, symptomatic reflux4 and obesity5 were found to be strong independent risk factors for these tumors, particularly for esophageal adenocarcinoma.4-5 Endoscopic surveillance of persons with reflux has been suggested,6 but the benefits and efforts are unknown.

Methods

In this reanalysis of Swedish nationwide case-control data collected in 1995-1997, we estimated the number of endoscopies needed to identify 1 esophageal or gastric cardia adenocarcinoma in persons with various combinations of obesity and reflux, including collaboration with all 195 relevant Swedish hospital departments and all cancer registries in Sweden. Our population-based study encompassed a comprehensive organization with rapid and prospective case ascertainment, uniform tumor classification, and face-to-face interviews.4 We . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Rising Incidence of Adenocarcinoma of the Esophagus and nGastric Cardia
William J. Blot, Susan S. Devesa, Robert W. Kneller, and Joseph F. Fraumeni, Jr
JAMA. 1991;265(10):1287-1289.
ABSTRACT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Anthropometry and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Steffen et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2079-2089.
ABSTRACT | FULL TEXT  

Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus
Whiteman et al.
Gut 2008;57:173-180.
ABSTRACT | FULL TEXT  

Dilemmas in managing Barrett's oesophagus
DTB 2006;44:69-72.
ABSTRACT | FULL TEXT  

Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?
Lagergren
Gut 2005;54:i1-i5.
ABSTRACT | FULL TEXT  

Gastroesophageal Reflux, Barrett Esophagus, and Esophageal Cancer: Scientific Review
Shaheen and Ransohoff
JAMA 2002;287:1972-1981.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.